Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine andl-DOPA
- 9 September 1985
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 342 (2), 401-404
- https://doi.org/10.1016/0006-8993(85)91146-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Neurochemical investigations in vitro with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in preparations of rat brainEuropean Journal of Pharmacology, 1984
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Inhibition of dopamine uptake by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, a cause of parkinsonismBiochemical and Biophysical Research Communications, 1984
- Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Dopamine release in rat striatum after administration ofl-DOPA as studied with in vivo electrochemistryBrain Research, 1981
- Long‐term administration of L‐DOPA does not damage dopaminergic neurons in the mouseNeurology, 1981
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979